Allan Andersen

NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.

Udviklingsselskabet af 01.08.1975 A/S is a holding company that engages in portfolio investment and property development. Its porfolios include residential, shopping centers, hotels, offices, holiday homes and resorts. The company operates through the Investment and Development segments. The Investment segment acquires and manages commercial and residential properties. The Development segment develops residential and commercial property projects which include construction of new buildings and refurbishment of existing properties. The company was founded on August 1, 1975 and is headquartered in Copenhagen, Denmark.

Greater Europe Deep Value Fund Ltd acquires minority stakes in the Russian electricity sector (electricity distribution companies), real estate (land development), financial services and consumer goods.